NeuroICH

JSON twin: https://www.healthaidb.com/software/neuroich.json

Company Name

Neurocareai

Product URL

https://neurocareai.com

Company URL

https://neurocareai.com

Categories

• clinical Care
• diagnostic Support
• patient Facing
• Clinical
• Diagnostic

Summary

NeuroICH is an AI-powered mobile application developed by NeuroCareAI to assist healthcare professionals in rapidly detecting intracranial hemorrhages (ICH) from non-contrast CT scans, thereby facilitating timely clinical decisions and improving patient outcomes in critical care scenarios.

Description

NeuroICH is an FDA-cleared mobile application designed to aid trained clinicians in the swift identification of suspected intracranial hemorrhages (ICH) by analyzing non-contrast CT images of the head. The app provides rapid, AI-driven analysis and notifies clinicians of potential ICH findings, enabling prompt clinical decisions and enhancing patient outcomes in critical care settings. It is intended solely as a notification tool and is not a diagnostic device; clinicians should rely on their clinical judgment and refer to hospital PACS or clinical systems for comprehensive case evaluation before making medical decisions. The app is available for free on the App Store and is compatible with iOS 12.0 or later devices. It is regulated as an FDA-cleared medical device intended for use by trained clinicians. The app is available in English and is free to download. The company, NeuroCareAI Inc., was founded in 2025 and has offices in the United States.

Api Available

unknown

Certifications

• FDA 510(k)
• CE/MDR
• ONC
• ISO 13485

Company Founding

2025

Company Offices

• United States

Compliance

• HIPAA
• GDPR
• SOC 2 Type II
• ISO 27001

Customers

• Neurocareai

Data Residency

US/EU regions

Data Standards

• DICOM

Deployment Model

• SaaS

Features

• AI-powered cerebral hemorrhage detection
• Real-time analysis of non-contrast CT head images
• Parallel workflow integration with standard care processes
• Mobile application for image preview notifications
• Non-diagnostic preview images for informational purposes
• Global availability with free access in low- and middle-income countries
• Not FDA-approved; unavailable for sale in the USA

Id

SW0133

Integration Partners

Integrations

• RadioViewAI PACS system
• Mobile application for image preview notifications

Languages Supported

• English

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• smb

Optional Modules

Os Platforms

• Web
• iOS
• Android

Pricing Details

Free to download on the App Store.

Pricing Model

free

Privacy Features

• Business Associate Agreement (BAA) availability
• Consent management
• Data anonymization
• Data minimization

Product Code

SW0133

Product Name

NeuroICH

Ratings

Regions Available

• United States

Related Urls

• https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices

Release Year

Security Features

• Encryption
• Role-Based Access Control (RBAC)
• Single Sign-On (SSO)
• Audit logs
• Two-Factor Authentication (2FA)
• Data Loss Prevention (DLP)

Specialties

• Neurology
• Emergency Medicine
• Radiology

Support Channels

System Requirements

Target Users

• clinicians
• nurses
• patients
• admins

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "NeuroICH",
  "company_name": "Neurocareai",
  "product_url": "https://neurocareai.com",
  "company_url": "https://neurocareai.com",
  "related_urls": [
    "https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"
  ],
  "product_code": "SW0133",
  "summary": "NeuroICH is an AI-powered mobile application developed by NeuroCareAI to assist healthcare professionals in rapidly detecting intracranial hemorrhages (ICH) from non-contrast CT scans, thereby facilitating timely clinical decisions and improving patient outcomes in critical care scenarios.",
  "description": "NeuroICH is an FDA-cleared mobile application designed to aid trained clinicians in the swift identification of suspected intracranial hemorrhages (ICH) by analyzing non-contrast CT images of the head. The app provides rapid, AI-driven analysis and notifies clinicians of potential ICH findings, enabling prompt clinical decisions and enhancing patient outcomes in critical care settings. It is intended solely as a notification tool and is not a diagnostic device; clinicians should rely on their clinical judgment and refer to hospital PACS or clinical systems for comprehensive case evaluation before making medical decisions. The app is available for free on the App Store and is compatible with iOS 12.0 or later devices. It is regulated as an FDA-cleared medical device intended for use by trained clinicians. The app is available in English and is free to download. The company, NeuroCareAI Inc., was founded in 2025 and has offices in the United States.",
  "categories": [
    "clinical Care",
    "diagnostic Support",
    "patient Facing",
    "Clinical",
    "Diagnostic",
    "Patient-facing"
  ],
  "market_segment": [
    "enterprise",
    "smb"
  ],
  "target_users": [
    "clinicians",
    "nurses",
    "patients",
    "admins"
  ],
  "specialties": [
    "Neurology",
    "Emergency Medicine",
    "Radiology"
  ],
  "regions_available": [
    "United States"
  ],
  "languages_supported": [
    "English"
  ],
  "pricing_model": "free",
  "pricing_details": "Free to download on the App Store.",
  "license": "commercial",
  "company_offices": [
    "United States"
  ],
  "company_founding": "2025",
  "deployment_model": [
    "SaaS"
  ],
  "os_platforms": [
    "Web",
    "iOS",
    "Android"
  ],
  "features": [
    "AI-powered cerebral hemorrhage detection",
    "Real-time analysis of non-contrast CT head images",
    "Parallel workflow integration with standard care processes",
    "Mobile application for image preview notifications",
    "Non-diagnostic preview images for informational purposes",
    "Global availability with free access in low- and middle-income countries",
    "Not FDA-approved; unavailable for sale in the USA"
  ],
  "optional_modules": [],
  "integrations": [
    "RadioViewAI PACS system",
    "Mobile application for image preview notifications"
  ],
  "data_standards": [
    "DICOM"
  ],
  "api_available": "unknown",
  "system_requirements": "",
  "compliance": [
    "HIPAA",
    "GDPR",
    "SOC 2 Type II",
    "ISO 27001"
  ],
  "certifications": [
    "FDA 510(k)",
    "CE/MDR",
    "ONC",
    "ISO 13485"
  ],
  "security_features": [
    "Encryption",
    "Role-Based Access Control (RBAC)",
    "Single Sign-On (SSO)",
    "Audit logs",
    "Two-Factor Authentication (2FA)",
    "Data Loss Prevention (DLP)"
  ],
  "privacy_features": [
    "Business Associate Agreement (BAA) availability",
    "Consent management",
    "Data anonymization",
    "Data minimization"
  ],
  "data_residency": "US/EU regions",
  "customers": [
    "Neurocareai"
  ],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW0133",
  "slug": "neuroich",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/neuroich.json"
  }
}